LIEBERMAN GERALD M 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Jun 9, 2025
Insider Transaction Report
Form 4
LIEBERMAN GERALD M
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-06-06+9,632→ 115,657 total - Exercise/Conversion
Restricted Share Units
2025-06-06−9,632→ 0 total→ Ordinary Shares (9,632 underlying) - Award
Restricted Share Units
2025-06-05+14,492→ 14,492 total→ Ordinary Shares (14,492 underlying)
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on June 6, 2024 and vested on June 6, 2025.
- [F4]Restricted share units were granted on June 5, 2025 and vest on June 5, 2026.